Bespak, a main contract development and manufacturing organization (CDMO) focused on orally breathed-in and nasal drug-device gadget blend items, and H&T Presspart, a pharmaceutical firm, declared a coordinated effort to speed up the business...
Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical organization entirely claimed by Ahmedabad-settled Zydus Lifesciences, as of late finished the procurement of worldwide exclusive rights for Zokinvy. Zokinvy is the first and only...
Context Therapeutics Inc, a biopharmaceutical firm creating therapies for solid tumors based in Philadelphia, reported that the US FDA has approved its Investigational New Drug application for CTIM-76, a bispecific antibody that targets Claudin 6...
Cocrystal Pharma, Inc. reports that the randomized, double-blind, placebo-controlled phase 2a human challenge clinical study assessing the safety, tolerability, antiviral, and clinical measurements of its novel, oral PB2 inhibitor CC-42344, which...
Abbott, the global healthcare company,announced the launch of XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE™ family, now available to people suffering...
The 4th Annual Pharma GMP & Quality Management 2024, held at NOVOTEL Mumbai International Airport on April 25th and 26th, emerged as a pivotal event in the pharmaceutical industry landscape, fostering collaboration, innovation, and excellence.